A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine

NCT05445440 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Methotrexate
DRUG: Leucovorin
DRUG: BMS-986371
DRUG: Sulfasalazine

Sponsor

Bristol-Myers Squibb